Funded PhD scholarship to develop new treatment strategies and discover new biomarkers for devastating chronic lung diseases.
Chronic lung diseases such as COPD/emphysema, asthma, lung fibrosis and lung cancer remain leading causes of premature death and there is an urgent need to develop new treatments.
RMIT funded scholarship provides a stipend of $33,826 per annum (pro-rata) for 3 years.
Open now.
31/12/2023
One (1).
Standard RMIT PhD enrolment requirement. Open to Domestic and International Students.
All applicants should email the following to Prof. Steven Bozinovski via steven.bozinovski@rmit.edu.au:
Preferable background and/or previous experience or publications in molecular biology, lung physiology, pharmacology. Experience or strong interest in respiratory sciences.
Acknowledgement of Country
RMIT University acknowledges the people of the Woi wurrung and Boon wurrung language groups of the eastern Kulin Nation on whose unceded lands we conduct the business of the University. RMIT University respectfully acknowledges their Ancestors and Elders, past and present. RMIT also acknowledges the Traditional Custodians and their Ancestors of the lands and waters across Australia where we conduct our business - Artwork 'Sentient' by Hollie Johnson, Gunaikurnai and Monero Ngarigo.